B\u0259zi xarici k\u00fctl\u0259vi informasiya vasit\u0259l\u0259rinin m\u0259lumat\u0131na g\u00f6r\u0259, AB\u015e-d\u0259 v\u0259 Avropada “Nimesil” d\u0259rman vasit\u0259si qada\u011fan olunub. S\u0259b\u0259bini is\u0259 onunla \u0259sasland\u0131r\u0131rlar ki, “Nimesil”in \u00e7oxsayl\u0131 f\u0259sadlar\u0131 var. M\u0259s\u0259l\u0259n, s\u00f6z\u00fcged\u0259n a\u011fr\u0131k\u0259sicinin selikli qi\u015fan\u0131, m\u0259d\u0259nin divarlar\u0131n\u0131 \u0259ritdiyi, toksiklik d\u0259r\u0259c\u0259si yuxar\u0131 oldu\u011fu \u00fc\u00e7\u00fcn qaraciy\u0259ri da\u011f\u0131td\u0131\u011f\u0131, m\u0259d\u0259d\u0259 yanma hissi yaratd\u0131\u011f\u0131, b\u0259z\u0259n qanaxmaya s\u0259b\u0259b oldu\u011fu vur\u011fulan\u0131r.<\/p>\n
Maraql\u0131d\u0131r ki, Az\u0259rbaycanda bu preparat qada\u011fan oluna bil\u0259rmi? Bu sualla S\u0259hiyy\u0259 Nazirliyi Analitik Ekspertiza M\u0259rk\u0259zin\u0259 \u00fcz tutduq.<\/p>\n
AEM-d\u0259n\u00a0Oxu.Az-\u0131n sor\u011fusuna cavab olaraq qeyd olunub ki, nimesulid t\u0259rkibli d\u0259rman vasit\u0259l\u0259rinin qada\u011fan edilm\u0259si v\u0259 ya m\u0259hdudla\u015fd\u0131r\u0131lmas\u0131 il\u0259 ba\u011fl\u0131 q\u0259rarlar milli t\u0259nziml\u0259m\u0259 yana\u015fmalar\u0131ndan as\u0131l\u0131d\u0131r:<\/p>\n
“Bel\u0259 ki, bir qrup \u00f6lk\u0259l\u0259rd\u0259 riskl\u0259ri olan preparatlar\u0131n preventiv \u015f\u0259kild\u0259 bazardan \u00e7\u0131xar\u0131lmas\u0131na \u00fcst\u00fcnl\u00fck verilir (AB\u015e, Avstraliya v\u0259 sair). Dig\u0259r bir qrup \u00f6lk\u0259l\u0259rd\u0259 \u0259g\u0259r riskl\u0259r idar\u0259 edil\u0259 bilirs\u0259, yana\u015fma olaraq daha \u00e7ox m\u0259hdudiyy\u0259t strategiyas\u0131 t\u0259tbiq olunur. Bu qrup \u00f6lk\u0259l\u0259r\u0259 T\u00fcrkiy\u0259, Rusiya, Ukrayna, Belarus v\u0259 sair aid etm\u0259k olar.<\/p>\n
B\u0259zi \u00f6lk\u0259l\u0259rd\u0259 nimesulidin istifad\u0259si m\u0259hdudla\u015fd\u0131r\u0131lm\u0131\u015f olsa v\u0259 ya qada\u011fan edils\u0259 d\u0259, bir \u00e7ox \u00f6lk\u0259l\u0259rd\u0259 (\u0130taliya, T\u00fcrkiy\u0259, Pol\u015fa, Xorvatiya, Bolqar\u0131stan, Macar\u0131stan, Finlandiya, Yunan\u0131stan, Meksika, Braziliya, Latviya, Litva, Malta, Kipr, Rusiya, T\u00fcrkm\u0259nistan, Ukrayna, \u00d6zb\u0259kistan, Belarus, G\u00fcrc\u00fcstan, Qazax\u0131stan, Q\u0131r\u011f\u0131z\u0131stan v\u0259 s.) istifad\u0259sin\u0259 icaz\u0259 verilib.<\/p>\n
Bu t\u0259rkibli d\u0259rman vasit\u0259l\u0259ri \u00f6lk\u0259mizd\u0259, d\u0259rman vasit\u0259si il\u0259 \u0259laq\u0259li m\u00fcvafiq t\u00f6vsiy\u0259l\u0259r\u0259 (q\u0131sa m\u00fcdd\u0259tli istifad\u0259si, resept \u0259sas\u0131nda burax\u0131lmas\u0131, ciddi h\u0259kim n\u0259zar\u0259ti alt\u0131nda t\u0259yin edilm\u0259si) riay\u0259t edil\u0259r\u0259k, nimesulidin faydas\u0131n\u0131n potensial riskl\u0259rind\u0259n \u00fcst\u00fcn oldu\u011fu q\u0259rar\u0131 verildikd\u0259n sonra istifad\u0259sini n\u0259z\u0259r\u0259 alaraq v\u0259 bir s\u0131ra farmakon\u0259zar\u0259t t\u0259dbirl\u0259rinin icras\u0131 \u015f\u0259rti il\u0259 (d\u0259rman vasit\u0259sinin t\u0259hl\u00fck\u0259sizlik profilinin davaml\u0131 izl\u0259nilm\u0259si) qeydiyyata al\u0131n\u0131b”.<\/p>\n
M\u0259lumatda vur\u011fulan\u0131b ki, m\u00f6vcud hepatotoksiklik riskini idar\u0259 ed\u0259 bilm\u0259k \u00fc\u00e7\u00fcn nimesulid t\u0259rkibli d\u0259rman vasit\u0259l\u0259rinin (n\u00fcmun\u0259 \u00fc\u00e7\u00fcn “Nimesil”) i\u00e7lik v\u0259r\u0259q\u0259sinin (x\u0259st\u0259l\u0259r \u00fc\u00e7\u00fcn) m\u00fcvafiq b\u00f6lm\u0259l\u0259ri vasit\u0259sil\u0259 (\u0130stifad\u0259sin\u0259 g\u00f6st\u0259ri\u015fl\u0259r, \u018fks-g\u00f6st\u0259ri\u015fl\u0259r, X\u00fcsusi g\u00f6st\u0259ri\u015fl\u0259r v\u0259 ehtiyat t\u0259dbirl\u0259ri, \u018flav\u0259 t\u0259sirl\u0259ri, Dig\u0259r d\u0259rman vasit\u0259l\u0259ri il\u0259 qar\u015f\u0131l\u0131ql\u0131 t\u0259siri v\u0259 s.) tan\u0131\u015f olmaq m\u00fcmk\u00fcnd\u00fcr:<\/p>\n
“\u0130\u00e7lik v\u0259r\u0259q\u0259sin\u0259 \u0259lav\u0259 edil\u0259n bu m\u0259lumatlar onun qaraciy\u0259r toksikliyi riski v\u0259 dig\u0259r \u0259lav\u0259 t\u0259sirl\u0259rinin n\u0259zar\u0259t\u0259 al\u0131nmas\u0131na v\u0259 minimalla\u015fd\u0131r\u0131lmas\u0131na imkan verir.<\/p>\n
Bildiririk ki, bu qrup d\u0259rman vasit\u0259l\u0259ri h\u0259kim resepti \u0259sas\u0131nda burax\u0131l\u0131r v\u0259 bir m\u00fcalic\u0259 kursu \u00e7\u0259r\u00e7iv\u0259sind\u0259 m\u00fcmk\u00fcn q\u0259d\u0259r q\u0131sa m\u00fcdd\u0259t \u0259rzind\u0259 v\u0259 15 g\u00fcnd\u0259n \u00e7ox olmamaqla istifad\u0259 edilm\u0259lidir. \u00dcmumiyy\u0259tl\u0259, bu kimi riskl\u0259ri olan d\u0259rman vasit\u0259l\u0259rini t\u0259yin etm\u0259zd\u0259n \u0259vv\u0259l m\u00fcalic\u0259 h\u0259kiminiz t\u0259r\u0259find\u0259n bu d\u0259rman vasit\u0259sinin faydalar\u0131 v\u0259 m\u00fcmk\u00fcn \u0259lav\u0259 t\u0259sirl\u0259ri aras\u0131ndak\u0131 nisb\u0259t qiym\u0259tl\u0259ndirilm\u0259lidir. Eyni zamanda onu da qeyd etm\u0259k ist\u0259rdik ki, nimesulid t\u0259rkibli d\u0259rman vasit\u0259l\u0259ri xroniki x\u0259st\u0259likl\u0259rin m\u00fcalic\u0259sind\u0259 istifad\u0259 edil\u0259n d\u0259rman vasit\u0259l\u0259rind\u0259n deyil. Bu d\u0259rman vasit\u0259si bird\u0259f\u0259lik a\u011fr\u0131n\u0131 aradan qald\u0131rmaq \u00fc\u00e7\u00fcn istifad\u0259 olunur v\u0259 m\u0259hdud istifad\u0259 g\u00f6st\u0259ri\u015fl\u0259ri il\u0259 v\u0259 qaraciy\u0259r toksikliyi riski n\u0259z\u0259r\u0259 al\u0131naraq qeydiyyatdan ke\u00e7ib. H\u0259m\u00e7inin m\u00fcvafiq riskl\u0259r t\u0259r\u0259fimizd\u0259n n\u0259zar\u0259td\u0259dir v\u0259 izl\u0259nilm\u0259y\u0259 davam edilir”.<\/p>\n
Bildirilib ki, nimesulid t\u0259rkibli d\u0259rman vasit\u0259l\u0259rinin istifad\u0259si yaln\u0131z h\u0259kimin fayda-risk qiym\u0259tl\u0259ndirm\u0259sin\u0259 \u0259sas\u0259n m\u00fcmk\u00fcnd\u00fcr v\u0259 resept \u0259sas\u0131nda burax\u0131l\u0131r:<\/p>\n
“Yuxar\u0131da qeyd olunan m\u0259s\u0259l\u0259 bir daha “Elektron resept” v\u0259 “D\u0259rman vasit\u0259l\u0259rinin t\u0259qib v\u0259 izl\u0259m\u0259” sisteml\u0259rinin \u0259h\u0259miyy\u0259tini vur\u011fulay\u0131r. Bel\u0259 ki, bu sisteml\u0259rin birg\u0259 istifad\u0259si il\u0259 \u00f6lk\u0259mizd\u0259 f\u0259aliyy\u0259t g\u00f6st\u0259r\u0259n p\u0259rak\u0259nd\u0259 sat\u0131\u015f \u0259cza\u00e7\u0131l\u0131q m\u00fc\u0259ssis\u0259l\u0259rind\u0259 (aptekl\u0259rd\u0259) h\u0259kim resepti \u0259sas\u0131nda burax\u0131lan d\u0259rman vasit\u0259l\u0259rinin resept olmadan sat\u0131lmas\u0131 m\u00fcmk\u00fcn olmayacaq. D\u0259rman vasit\u0259l\u0259rinin t\u0259qib v\u0259 izl\u0259m\u0259 sistemi vasit\u0259sil\u0259 h\u0259min d\u0259rman vasit\u0259l\u0259rinin sat\u0131\u015f\u0131 h\u0259yata ke\u00e7iril\u0259rk\u0259n onlar\u0131n t\u0259yin edildiyi elektron reseptin qeydiyyat n\u00f6mr\u0259si t\u0259l\u0259b olunacaq v\u0259 h\u0259min reseptin do\u011frulu\u011fu sistem vasit\u0259sil\u0259 yoxlan\u0131lacaq. H\u0259r iki sistemd\u0259 m\u0259lumatlar uy\u011fun oldu\u011fu t\u0259qdird\u0259, h\u0259kim resepti \u0259sas\u0131nda burax\u0131lan d\u0259rman vasit\u0259l\u0259rinin sat\u0131\u015f\u0131n\u0131n h\u0259yata ke\u00e7irilm\u0259si m\u00fcmk\u00fcn olacaq. \u018fks t\u0259qdird\u0259 h\u0259min d\u0259rman vasit\u0259l\u0259rinin sat\u0131\u015f\u0131 m\u00fcmk\u00fcn olmayacaq.<\/p>\n
S\u00f6z\u00fcged\u0259n sisteml\u0259r y\u00fcks\u0259k risk qrupundan olan d\u0259rman vasit\u0259l\u0259rinin \u0259hali aras\u0131nda sui-istifad\u0259 hallar\u0131n\u0131n qar\u015f\u0131s\u0131n\u0131n al\u0131nmas\u0131na, d\u0259rman vasit\u0259l\u0259rinin rasional istifad\u0259sinin t\u0259\u015fkil olunmas\u0131na v\u0259 onlar\u0131n aptekl\u0259rd\u0259 burax\u0131l\u0131\u015f\u0131 prosesin\u0259 dair daha ciddi t\u0259nziml\u0259m\u0259 mexanizminin yarad\u0131lmas\u0131na xidm\u0259t edir”.<\/p>\n
Sonda v\u0259t\u0259nda\u015flara xat\u0131rlad\u0131l\u0131b ki, \u00f6z\u0259l tibb m\u00fc\u0259ssis\u0259l\u0259rind\u0259 v\u0259 aptek t\u0259\u015fkilatlar\u0131nda \u00fczl\u0259\u015fdikl\u0259ri h\u0259r hans\u0131 probleml\u0259 ba\u011fl\u0131 insnalar AEM-in “bir p\u0259nc\u0259r\u0259” sistemi, “qaynar x\u0259tt”i (012 596 07 12),\u00a0aem@pharma.az\u00a0elektron \u00fcnvan\u0131 v\u0259 ya pharma.az sayt\u0131n\u0131n “M\u00fcraci\u0259t” b\u00f6lm\u0259si vasit\u0259si il\u0259 m\u00fcraci\u0259t ed\u0259 bil\u0259rl\u0259r:<\/p>\n
“Bu halda ara\u015fd\u0131r\u0131lma apar\u0131l\u0131r v\u0259 laz\u0131m g\u0259l\u0259rs\u0259, plandank\u0259nar yoxlaman\u0131n ke\u00e7irilm\u0259si bar\u0259d\u0259 q\u0259rar q\u0259bul edilir”.<\/p>\n","protected":false},"excerpt":{"rendered":"
B\u0259zi xarici k\u00fctl\u0259vi informasiya vasit\u0259l\u0259rinin m\u0259lumat\u0131na g\u00f6r\u0259, AB\u015e-d\u0259 v\u0259 Avropada “Nimesil” d\u0259rman vasit\u0259si qada\u011fan olunub. S\u0259b\u0259bini is\u0259 onunla \u0259sasland\u0131r\u0131rlar ki,<\/p>\n","protected":false},"author":1,"featured_media":22719,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[29,35],"tags":[],"class_list":["post-22718","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-manset","category-olk"],"aioseo_notices":[],"jetpack_featured_media_url":"https:\/\/basta2.com\/wp-content\/uploads\/2025\/02\/HSz0bbmF6ZmvZbFb8t9oKMiOaYDDEsaQVsEPzSFp_1200.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/basta2.com\/index.php?rest_route=\/wp\/v2\/posts\/22718","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/basta2.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/basta2.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/basta2.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/basta2.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=22718"}],"version-history":[{"count":1,"href":"https:\/\/basta2.com\/index.php?rest_route=\/wp\/v2\/posts\/22718\/revisions"}],"predecessor-version":[{"id":22720,"href":"https:\/\/basta2.com\/index.php?rest_route=\/wp\/v2\/posts\/22718\/revisions\/22720"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/basta2.com\/index.php?rest_route=\/wp\/v2\/media\/22719"}],"wp:attachment":[{"href":"https:\/\/basta2.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=22718"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/basta2.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=22718"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/basta2.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=22718"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}